A deadly meningococcal meningitis outbreak linked to the University of Kent in England has infected at least 29 people and claimed two lives as of March 19. Health authorities contacted thousands due to potential exposure.
The outbreak, driven by group B Neisseria meningitidis, underscores how quickly the disease spreads in close-quarter settings like college dorms. Symptoms-fever, headache, rash-can escalate within hours to coma or death. Survivors often face permanent complications including hearing loss or limb amputations.
Public health teams are deploying antibiotics for exposed individuals and launching an emergency MenB vaccination campaign. While MenACWY and MenB vaccines are available in both the U.K. and U.S., this strain specifically requires MenB protection, which is most effective shortly after administration-highlighting the need for adolescent boosters before entering high-risk environments.